Annual Working Capital
$617.16 M
+$256.13 M+70.94%
March 31, 2024
Summary
- As of February 12, 2025, IMVT annual working capital is $617.16 million, with the most recent change of +$256.13 million (+70.94%) on March 31, 2024.
- During the last 3 years, IMVT annual working capital has risen by +$226.93 million (+58.15%).
- IMVT annual working capital is now at all-time high.
Performance
IMVT Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$344.23 M
-$96.49 M-21.89%
December 31, 2024
Summary
- As of February 12, 2025, IMVT quarterly working capital is $344.23 million, with the most recent change of -$96.49 million (-21.89%) on December 31, 2024.
- Over the past year, IMVT quarterly working capital has dropped by -$334.45 million (-49.28%).
- IMVT quarterly working capital is now -49.28% below its all-time high of $678.67 million, reached on December 31, 2023.
Performance
IMVT Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
IMVT Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +70.9% | -49.3% |
| 3 y3 years | +58.1% | -31.7% |
| 5 y5 years | +558.3% | +207.9% |
IMVT Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +70.9% | -49.3% | +37.2% |
| 5 y | 5-year | at high | >+9999.0% | -49.3% | +267.1% |
| alltime | all time | at high | >+9999.0% | -49.3% | >+9999.0% |
Immunovant Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $344.23 M(-21.9%) |
| Sep 2024 | - | $440.72 M(-19.0%) |
| Jun 2024 | - | $544.03 M(-11.8%) |
| Mar 2024 | $617.16 M(+70.9%) | $617.16 M(-9.1%) |
| Dec 2023 | - | $678.67 M(+170.5%) |
| Sep 2023 | - | $250.92 M(-16.0%) |
| Jun 2023 | - | $298.66 M(-17.3%) |
| Mar 2023 | $361.04 M(-22.9%) | $361.04 M(-12.6%) |
| Dec 2022 | - | $413.16 M(+4.8%) |
| Sep 2022 | - | $394.31 M(-9.4%) |
| Jun 2022 | - | $435.06 M(-7.1%) |
| Mar 2022 | $468.41 M | $468.41 M(-7.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | - | $504.13 M(-5.8%) |
| Sep 2021 | - | $535.41 M(+47.0%) |
| Jun 2021 | - | $364.30 M(-6.6%) |
| Mar 2021 | $390.24 M(+316.2%) | $390.24 M(-5.5%) |
| Dec 2020 | - | $412.94 M(-5.6%) |
| Sep 2020 | - | $437.46 M(+64.1%) |
| Jun 2020 | - | $266.57 M(+184.3%) |
| Mar 2020 | $93.76 M(<-9900.0%) | $93.76 M(-16.1%) |
| Dec 2019 | - | $111.81 M(+7747.1%) |
| Sep 2019 | - | $1.42 M(-28.1%) |
| Jun 2019 | - | $1.98 M(-1399.3%) |
| Mar 2019 | - | -$152.60 K |
| Dec 2018 | -$55.40 K | - |
FAQ
- What is Immunovant annual working capital?
- What is the all time high annual working capital for Immunovant?
- What is Immunovant annual working capital year-on-year change?
- What is Immunovant quarterly working capital?
- What is the all time high quarterly working capital for Immunovant?
- What is Immunovant quarterly working capital year-on-year change?
What is Immunovant annual working capital?
The current annual working capital of IMVT is $617.16 M
What is the all time high annual working capital for Immunovant?
Immunovant all-time high annual working capital is $617.16 M
What is Immunovant annual working capital year-on-year change?
Over the past year, IMVT annual working capital has changed by +$256.13 M (+70.94%)
What is Immunovant quarterly working capital?
The current quarterly working capital of IMVT is $344.23 M
What is the all time high quarterly working capital for Immunovant?
Immunovant all-time high quarterly working capital is $678.67 M
What is Immunovant quarterly working capital year-on-year change?
Over the past year, IMVT quarterly working capital has changed by -$334.45 M (-49.28%)